Physician profile
Mark M Youssef
NPI 1225200637
$113,404.13
in general payments reported to CMS, 2019-2025
13 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $33K · 2021: $25K · 2022: $12K · 2023: $19K · 2024: $9,440 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $3,015 · Travel and Lodging: $43.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,101.20 |
| Food and Beverage | $3,015.12 |
| Travel and Lodging | $43.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $94,020.71 | 2019-2025 | Dysport |
| Allergan, INC. | $15,293.50 | 2019-2023 | |
| Merz North America, INC. | $2,613.95 | 2019-2025 | Xeomin |
| Abbvie INC. | $612.54 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Revance Therapeutics, INC. | $383.80 | 2024-2025 | Daxxify, Daxi |
| Tepha INC | $145.51 | 2019 | |
| Intuitive Surgical, INC. | $113.75 | 2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $72.41 | 2019-2021 | |
| Gramercy Extremity Orthopedics LLC | $71.06 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $31.29 | 2022 | |
| Innovation Technologies INC | $22.30 | 2022 | |
| Novo Nordisk INC | $14.12 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $9.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.